Diabetes Mellitus News and Research RSS Feed - Diabetes Mellitus News and Research

Diabetes mellitus is a severe and debilitating chronic disease that develops in nearly 5 percent of the world’s population. People with this disease have a shortage of insulin or a reduced ability to use insulin, the hormone regulating blood glucose levels, which is normally produced by the pancreas. In the United States alone, an estimated 18 million people have diabetes, and each year about 1 million Americans are diagnosed with the disease. It is the sixth leading cause of death in the US and is responsible for over 200,000 deaths a year. Insulin-dependent (type I) diabetes accounts for around 10% of diabetics. For those patients, suffering from an inability of their pancreas to produce insulin, the only practical treatment possible is regular insulin replacement by multiple daily injections. Transplantation of a pancreas or pancreatic tissue would be beneficial to millions of such patients in that it would restore their normal ability to produce self insulin. Transplantation of human pancreas or pancreatic islets is a practiced and time-honored such therapeutic approach, but is extremely limited by the severe shortage of human donor organs. Tissera's R&D efforts in this domain are directed towards the development of a universally available and reliable source of animal fetal donor pancreatic precursor tissue, suitable for transplantation and eventual normal structural and functional growth in human diabetics.
Maternal GDM linked to increased risk of childhood obesity among children aged 9-11 years

Maternal GDM linked to increased risk of childhood obesity among children aged 9-11 years

New research published in Diabetologia shows an increased risk of childhood obesity at age 9-11 years when the mother has had gestational diabetes during pregnancy. [More]
Study shows overall prevalence of diabetic kidney disease remains unchanged among U.S. adults

Study shows overall prevalence of diabetic kidney disease remains unchanged among U.S. adults

Among U.S. adults with diabetes from 1988 to 2014, the overall prevalence of diabetic kidney disease did not change significantly, while the prevalence of albuminuria declined and the prevalence of reduced estimated glomerular filtration rate increased, according to a study appearing in the August 9 issue of JAMA. [More]
Emperra launches world’s first Bluetooth insulin pen to improve diabetes management

Emperra launches world’s first Bluetooth insulin pen to improve diabetes management

Emperra GmbH based in Germany is launching the world’s first Bluetooth insulin pen on the market and therefore expanding its ESYSTA product system’s function. [More]
UAdeC scientists develop jelly-based shell granada to help lower blood sugar levels

UAdeC scientists develop jelly-based shell granada to help lower blood sugar levels

The development reduces the excess blood glucose and cheap to produce and easy. To innovate in natural treatments easy access to the Mexican population to combat diabetes, scientists from the Autonomous University of Coahuila developed a jelly-based shell Granada that meets as a functional food to lower blood sugar levels, it say, excess blood sugar. [More]
DRG International to display Hepcidin 25 (bioactive) HS ELISA Kit at 2016 AACC Expo

DRG International to display Hepcidin 25 (bioactive) HS ELISA Kit at 2016 AACC Expo

DRG International, a leading international medical diagnostic company, will showcase the NEW DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04. [More]
Researchers identify biomarkers to improve prognosis of CKD

Researchers identify biomarkers to improve prognosis of CKD

Currently, there is no effective method to predict the prognosis of chronic kidney disease (CKD) patients. [More]
Sleep researchers call for new diagnostic criteria to treat OSA in pregnant women

Sleep researchers call for new diagnostic criteria to treat OSA in pregnant women

Recent studies reveal that approximately one quarter of pregnant women may suffer from Obstructive Sleep Apnea (OSA), the recurrent cessation or limitation of normal breathing during sleep. [More]
Older Japanese patients exhibit most resilience after triple disaster, study reveals

Older Japanese patients exhibit most resilience after triple disaster, study reveals

Research into the aftermath of the Fukushima earthquake, tsunami and subsequent nuclear meltdown found that the oldest were least likely to experience a deterioration of existing chronic conditions. [More]
Diabetes Professional Care conference unveils speaker line-up for 2016

Diabetes Professional Care conference unveils speaker line-up for 2016

Diabetes Professional Care 2016, the leading free-to-attend two-day CPD accredited conference and exhibition has unveiled its speaker line-up for 2016, which includes keynote presentations from NHS England and The Diabetes Think Tank. [More]
New diagnostic model may become cheaper and easier alternative to screen for NAFLD

New diagnostic model may become cheaper and easier alternative to screen for NAFLD

Researchers have developed a diagnostic model that is highly predictive of nonalcoholic fatty liver disease (NAFLD). [More]
Boy babies more likely to experience complications at birth than girls

Boy babies more likely to experience complications at birth than girls

New research led by the University of Adelaide has confirmed that boy babies are much more likely to experience potentially life-threatening outcomes at birth than girls. [More]
New study suggests potential role for gut microbiota in diabetes remission after bypass surgery

New study suggests potential role for gut microbiota in diabetes remission after bypass surgery

Studies have shown that bariatric surgery can lead to remission of type 2 diabetes mellitus (T2DM) in rodents and humans, but this beneficial effect cannot be explained solely by weight loss. [More]
Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

The German Institute for Quality and Efficiency in Health Care assessed the added benefit of ticagrelor for patients with acute coronary syndrome already in 2011 in its very first dossier assessment, just after the Act on the Reform of the Market for Medicinal Products had come into force. [More]
Latest online version of German Diabetes Risk Score optimized for mobile devices

Latest online version of German Diabetes Risk Score optimized for mobile devices

The German Institute of Human Nutrition has updated the online version of its German Diabetes Risk Score and has optimized it for mobile devices. [More]
Kidney transplant recipients with inflammation prior to surgery more likely to develop diabetes

Kidney transplant recipients with inflammation prior to surgery more likely to develop diabetes

Up to 30 percent of people who receive organ transplants will develop diabetes, but researchers are unsure why. Although doctors typically blame immunosuppressive drugs that transplant recipients take to prevent organ rejection, it's unclear why some people develop the lifelong disorder, while others do not. [More]

Fixed-dose combination of sacubitril and valsartan for heart failure shows differing added benefit

The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function. [More]
MPC outperforms PID in automated insulin delivery for patients with type 1 diabetes mellitus

MPC outperforms PID in automated insulin delivery for patients with type 1 diabetes mellitus

The so-called artificial pancreas — an automated insulin delivery system for people with type 1 diabetes mellitus — uses an advanced control algorithm to regulate how much insulin a pump should deliver and when. Regulating glucose is challenging because levels respond to a wide-array of variables, including food, physical activity, sleep, stress, hormones, metabolism and more. [More]
New PsA-comorbidity index may help identify patients at risk of hospitalisation and premature death

New PsA-comorbidity index may help identify patients at risk of hospitalisation and premature death

The results of a study presented today at the European League Against Rheumatism Annual Congress showed that a newly developed method of evaluating the impact of different comorbidities in patients with Psoriatic Arthritis (PsA) can be used to prospectively identify those PsA patients at greater risk of hospitalisation and premature death. [More]
Study finds no added benefit of empagliflozin alone or in combination for type 2 diabetes

Study finds no added benefit of empagliflozin alone or in combination for type 2 diabetes

Empagliflozin has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. [More]
Innovative model identifies T2D trajectory and related risks

Innovative model identifies T2D trajectory and related risks

An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D. [More]
Advertisement